ABBV - Acadia Pharma ticks lower amid Deutsche Bank downgrade after surge on patent win
2023-12-14 11:34:23 ET
- Acadia Pharmaceuticals: Legal Overhang On Nuplazid Removed
- Acadia's Daybue: A Small Patient Pool Making Big Waves
- ACADIA Pharmaceuticals Inc. (ACAD) Q3 2023 Earnings Call Transcript
- Acadia Pharmaceuticals surges 32% after win in patent suit over Nuplazid (update)
- Acadia starts Phase 3 study for Prader-Willi hunger treatment
For further details see:
Acadia Pharma ticks lower amid Deutsche Bank downgrade after surge on patent win